• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MANUFACTURING INC CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MANUFACTURING INC CREATININE Back to Search Results
Model Number 3L81-22
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 10/11/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event or Problem Description
The customer reported a falsely increased creatinine result generated on the architect c4000 analyzer on one patient.Results provided: (b)(6) 2019 sid (b)(6) = 3.27 / 3.27 mg/dl; new sample collected = 0.94 / 0.89 mg/dl.Other results provide: bun = 11 mg/dl on both samples.No impact to patient management was reported.
 
Additional Manufacturer Narrative
The customer acknowledges issue was sample specific with the initial draw.No customer returns were available for evaluation.A review of ticket trending for architect creatinine reagent product lot number (88664un18) did not find any atypical complaint trends identified.The trend review by the product list number (3l81) found no trends related to this issue.Labeling, including sample handling procedures was reviewed and found to adequately address the issue under review.Manufacturing documentation for the likely cause lot did not identify any issues associated with the complaint issue.No product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE
Common Device Name
CREATININE
Manufacturer (Section D)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
MDR Report Key9259538
Report Number1628664-2019-00691
Device Sequence Number14090929
Product Code CGX
UDI-Device Identifier00380740005979
UDI-Public00380740005979
Combination Product (Y/N)N
Initial Reporter StateNE
Initial Reporter CountryUS
PMA/510(K) Number
K981799
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/17/2020
Device Model Number3L81-22
Device Catalogue Number03L81-22
Device Lot Number88664UN18
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/11/2019
Supplement Date Received by Manufacturer01/20/2020
Initial Report FDA Received Date10/31/2019
Supplement Report FDA Received Date01/20/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARCHITECT C4000 ANALYZER LIST 02P24-40; ARCHITECT C4000 ANALYZER LIST 02P24-40; SERIAL (B)(6); SERIAL (B)(6)
-
-